Relationship between tamoxifen use and high risk endometrial cancer histologic types-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Relationship between tamoxifen use and high risk endometrial cancer histologic types

Published:2009-01 Issue:1 Volume:112 Page:150-154
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Bland Amy E.,Calingaert Brian,Secord Angeles Alvarez,Lee Paula S.,Valea Fidel A.,Berchuck Andrew,Soper John T.,Havrilesky Laura

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference27 articles.

1. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women;N. Engl. J. Med.,1988

2. Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial;Ryden;Acta. Oncol.,1992

3. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group;Rutqvist;J. Natl. Cancer Inst.,1995

4. Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer;Andersson;J. Natl. Cancer Inst.,1991

5. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14;Fisher;J. Natl. Cancer Inst.,1994

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of breast cancer-related gene prognostic signature in endometrial cancer;2024-05-10

2. Gynecologic Care of Black Breast Cancer Survivors;Current Breast Cancer Reports;2024-02-19

3. Endometrial Carcinoma. Low-Grade Endometrioid Carcinoma;Gynecologic and Obstetric Pathology;2024

4. Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study;Clinical and Translational Oncology;2023-09-08

5. Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps;JCO Precision Oncology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3